Show simple item record

Putting GlaxoSmithKline to the test over paroxetine

dc.contributor.authorDoshi, Peter
dc.date.accessioned2017-05-25T01:19:05Z
dc.date.available2017-05-25T01:19:05Z
dc.date.issued2013-11-12
dc.identifier.citationDoshi, P. (2013). Putting GlaxoSmithKline to the test over paroxetine. BMJ, 347. DOI: 10.1136/bmj.f6754
dc.identifier.urihttp://hdl.handle.net/10713/6614
dc.descriptionAuthor discusses paroxetine, an antidepressant manufactured by GlaxoSmithKline, its use in adolescents, the controversy over Study 329, and the company's continued reticence to share all of its clinical trial data.
dc.description.urihttp://bmj.com/cgi/content/full/bmj.f6754?ijkey=daKgBqzhyNXwNUW&keytype=ref
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectresearch transparencyen_US
dc.subjectRestoring Invisible and Abandoned Trialsen_US
dc.subjectRIATen_US
dc.subjectStudy 329en_US
dc.subject.lcshGlaxoSmithKlineen_US
dc.subject.meshAccess to Informationen_US
dc.subject.meshAdolescenten_US
dc.subject.meshClinical Trials as Topicen_US
dc.subject.meshDepressionen_US
dc.subject.meshParoxetineen_US
dc.titlePutting GlaxoSmithKline to the test over paroxetineen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.f6754
dc.identifier.pmid24222673
dc.identifier.ispublishedNoen_US
dc.description.urinameClick here for the free full-text article on publisher’s websiteen_US
refterms.dateFOA2019-02-19T18:16:22Z


Files in this item

Thumbnail
Name:
Doshi_BMJ_GSK_paroxetine.pdf
Size:
229.3Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record